“Thursday, the Food and Drug Administration (FDA) is expected to amend emergency use authorizations this week for COVID-19 booster shots for immunocompromised people.
“This shot would be a third shot for those who have already received the first two doses of either Pfizer or Moderna vaccines, and are affected by immunocompromise. Those with the Johnson & Johnson vaccine will not be allowed extra doses at this time.
““We know that immunocompromised patients, particularly transplant patients, but definitely other forms of immunocompromise, don’t respond as well to the vaccine,” Beaumont Health Director of Infectious Disease Research Dr. Matthew Sims told 760 WJR’s Kevin Dietz.”
Read more at WJR
